These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. Carlesso N; Frank DA; Griffin JD J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285 [TBL] [Abstract][Full Text] [Related]
23. The BCR gene encodes a novel serine/threonine kinase activity within a single exon. Maru Y; Witte ON Cell; 1991 Nov; 67(3):459-68. PubMed ID: 1657398 [TBL] [Abstract][Full Text] [Related]
24. Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family. Reuther GW; Fu H; Cripe LD; Collier RJ; Pendergast AM Science; 1994 Oct; 266(5182):129-33. PubMed ID: 7939633 [TBL] [Abstract][Full Text] [Related]
25. Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2. Sánchez-García I; Grütz G Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5287-91. PubMed ID: 7777499 [TBL] [Abstract][Full Text] [Related]
26. Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS. Maru Y; Peters KL; Afar DE; Shibuya M; Witte ON; Smithgall TE Mol Cell Biol; 1995 Feb; 15(2):835-42. PubMed ID: 7529874 [TBL] [Abstract][Full Text] [Related]
27. Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. Chissoe SL; Bodenteich A; Wang YF; Wang YP; Burian D; Clifton SW; Crabtree J; Freeman A; Iyer K; Jian L Genomics; 1995 May; 27(1):67-82. PubMed ID: 7665185 [TBL] [Abstract][Full Text] [Related]
28. An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. McWhirter JR; Wang JY EMBO J; 1993 Apr; 12(4):1533-46. PubMed ID: 8467803 [TBL] [Abstract][Full Text] [Related]
29. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. Skorski T; Bellacosa A; Nieborowska-Skorska M; Majewski M; Martinez R; Choi JK; Trotta R; Wlodarski P; Perrotti D; Chan TO; Wasik MA; Tsichlis PN; Calabretta B EMBO J; 1997 Oct; 16(20):6151-61. PubMed ID: 9321394 [TBL] [Abstract][Full Text] [Related]
30. Intramolecular interactions of the regulatory domains of the Bcr-Abl kinase reveal a novel control mechanism. Nam HJ; Haser WG; Roberts TM; Frederick CA Structure; 1996 Sep; 4(9):1105-14. PubMed ID: 8805596 [TBL] [Abstract][Full Text] [Related]
31. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL. Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971 [TBL] [Abstract][Full Text] [Related]
32. Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein. Gotoh A; Miyazawa K; Ohyashiki K; Tauchi T; Boswell HS; Broxmeyer HE; Toyama K Exp Hematol; 1995 Oct; 23(11):1153-9. PubMed ID: 7556524 [TBL] [Abstract][Full Text] [Related]
33. Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. McWhirter JR; Wang JY Mol Cell Biol; 1991 Mar; 11(3):1553-65. PubMed ID: 1705008 [TBL] [Abstract][Full Text] [Related]
34. Role of the BCR-ABL oncogene in human leukemia: fifteenth Richard and Hinda Rosenthal Foundation Award Lecture. Witte ON Cancer Res; 1993 Feb; 53(3):485-9. PubMed ID: 8425181 [No Abstract] [Full Text] [Related]
35. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor. Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134 [TBL] [Abstract][Full Text] [Related]
36. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells. Sattler M; Pride YB; Quinnan LR; Verma S; Malouf NA; Husson H; Salgia R; Lipkowitz S; Griffin JD Oncogene; 2002 Feb; 21(9):1423-33. PubMed ID: 11857085 [TBL] [Abstract][Full Text] [Related]
37. The function of BCR/ABL and related proto-oncogenes. Gotoh A; Broxmeyer HE Curr Opin Hematol; 1997 Jan; 4(1):3-11. PubMed ID: 9050373 [TBL] [Abstract][Full Text] [Related]
38. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway. Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906 [TBL] [Abstract][Full Text] [Related]
39. Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells. Nieborowska-Skorska M; Slupianek A; Skorski T Oncogene; 2000 Aug; 19(36):4117-24. PubMed ID: 10962572 [TBL] [Abstract][Full Text] [Related]
40. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation. Xie S; Wang Y; Liu J; Sun T; Wilson MB; Smithgall TE; Arlinghaus RB Oncogene; 2001 Sep; 20(43):6188-95. PubMed ID: 11593427 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]